- | EYECRYL-SERT (N=41) | ||||
---|---|---|---|---|---|
Parameter |
Descriptive Statistics |
Screening |
PO 01 Month |
PO 03 Month |
PO 06 Month |
Sphere | N | 30 | 40 | 39 | 40 |
Mean (SD) | -1.35 (2.52) | 0.01 (0.50) | 0.10 (0.48) | 0.10 (0.55) | |
Median | -1.00 | 0.00 | 0.00 | 0.00 | |
Min, Max | -7.00, 6.00 | -1.00, 1.00 | -1.00, 1.00 | -1.00, 1.50 | |
p-value | - | 0.0123 | 0.0078 | 0.0090 | |
Sphere Ref Range [n(%)] | < -0.5 | 19 (46.34%) | 3 (7.32%) | 2 (4.88%) | 2 (4.88%) |
-0.5 - +0.5 | 7 (17.07%) | 30 (73.17%) | 30 (73.17%) | 29 (70.73%) | |
> +0.5 | 4 (9.76%) | 7 (17.07%) | 7 (17.07%) | 9 (21.95%) | |
Cylinder | N | 30 | 40 | 39 | 40 |
Mean (SD) | -1.18 (1.22) | -0.62 (0.52) | -0.63 (0.55) | -0.62 (0.51) | |
Median | -1.00 | -0.50 | -0.75 | -0.50 | |
Min, Max | -5.50, 0.50 | -2.00, 0.00 | -2.00, 0.50 | -2.00, 0.00 | |
p-value | - | 0.0138 | 0.0174 | 0.0181 | |
Cylinder Ref Range [n(%)] | < -0.5 | 19 (46.34%) | 18 (43.90%) | 20 (48.78%) | 18 (43.90%) |
-0.5 - +0.5 | 11 (26.83%) | 22 (53.66%) | 19 (46.34%) | 22 (53.66%) | |
> +0.5 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
Abbreviations: N=number of subjects in the specified treatment; n=number of subjects in the specified category. Note 1: The given interval is inclusive of both values. Note 2: When screening, visit data was not available. We considered 'PO 01 Month' visit data as baseline. Note 3: p-value for parameter sphere obtained by using paired t-test and for cylinder by using Wilcoxon signed rank test. |